Navigation Links
Tachycardia in Medical News

Cordex Pharma Files ATPace Formulation Patent

... acute management of paroxysmal supraventricular tachycardia (PSVT) as well as a diagnostic test for the ... have been clinically used to terminate tachycardia in certain cases. "We are very pleased with ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ...

Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace

... have been clinically used to terminate tachycardia in certain cases. About Cordex Pharma, Inc. ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ... for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, the ...

Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia

... and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. ... About Ventricular Fibrillation and Ventricular tachycardia Ventricular fibrillation is a condition in ... help is provided immediately. Ventricular tachycardia is a fast or rapid heart rate that starts in ...

Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers

... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial and CDP-1050's expected ...

Cordex Pharma Sets Fourth Quarter 2008 Program Update Call

... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected ...

Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis

... of a frequent cardiac arrhythmia called paroxysmal supraventricular tachycardia (PSVT). On April 16, 2008, Duska met with the FDA and confirmed that a ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and Duska's CDP-1050 is expected to commence a Phase 2 clinical trial for ...

Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)

... clinical trials evaluating its lead product ATPace(TM) as an antiarrhytmic drug for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT) under the Special Protocol Assessment (SPA) process. ATPace(TM) is a novel stable liquid formulation of adenosine 5'-triphosphate (ATP). ...

Expert consensus on catheter ablation of ventricular arrhythmias

... tachycardias that originate from the epicardial surface of the heart. The delineation of the relation between cardiac anatomy and focal ventricular tachycardia origins in the right and left ventricular outflow tracts and papillary muscles. ...

Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009

... daily clinical practice and scientific discovery. This year we are seeing an important increase in utilization for applications such as ventricular tachycardia and navigation of the unpredictable anatomy associated with congenital heart disease. Our customers report that magnetic navigation is uniquely ...

Vivek Y. Reddy, M.D., Joins The Mount Sinai Medical Center as Director of Electrophysiology Laboratories

... ablation of atrial fibrillation. He has published numerous articles, most famously a seminal multi-center clinical trial on ventricular tachycardia ablation. Known as SMASH-VT (Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia), the study examined the use of ...
Tachycardia in Medical Technology

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

... for the treatment of paroxysmal supraventricular tachycardia (PSVT). Under the agreement, a portion of Cato's ... have been clinically used to terminate tachycardia in certain cases. Cordex has submitted its ... for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to ...

Duska Therapeutics Completes Corporate Name Change to Cordex Pharma

... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement ...

Duska Therapeutics Applies for Phase 3 Special Protocol Assessment

... atrio-ventricular nodal conduction, have been clinically used to terminate tachycardia in certain cases. "The request for a SPA represents a significant ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in Q1 2009. Duska's CDP-1050 is expected to commence a Phase 2 clinical ...

Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program

... Reduction in tachycardia and Blood Acetaldehyde Levels in Subset of Subjects with Inborn Error of ... acetaldehyde levels produce acute symptoms, including facial flushing, tachycardia (rapid heart rate), headache, nausea and dizziness. Although ALDH2 ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia

... vs. 4% placebo), hot flush (11% vs. 4% placebo), dizziness (11% vs. 5% placebo), hyperhidrosis (8% vs. 1% placebo), palpitations (7% vs. 3% placebo), tachycardia (5% vs. 1% placebo), and hypertension (5% vs. 1%). Overall premature discontinuation rates (all causes including adverse event related) ...

FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)

... incidence (%) in these 98 patients: hypotension (50%), back pain (30%), dyspnea (28%), vasodilation (28%), rash (25%), chest pain or tightness (24%), tachycardia (12%), dysphagia or laryngismus (5%), syncope (3%), allergic reaction (1%), or anaphylaxis (1%). These events were severe in 2% of patients. -- ...

Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)

... serious health disorders. In addition to the long-term health risks, elevated acetaldehyde levels produce acute symptoms, including facial flushing, tachycardia (rapid heart rate), headache, nausea and dizziness. Although ALDH2 deficient people suffer from unpleasant reactions and face long-term health ...

IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology

... tolerated in all phases of study. Adverse events were mild to moderate in severity and included chills, fever, nausea, vomiting, myalgia, headache, tachycardia (fast heart rate), hypo- and hypertension, fatigue and shortness of breath, all of which are consistent events with the activation of monocytes ...

IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients

... tolerated in all phases of study. Adverse events were mild to moderate in severity and included chills, fever, nausea, vomiting, myalgia, headache, tachycardia (fast heart rate), hypo- and hypertension, fatigue and shortness of breath, all of which are consistent events with the activation of monocytes ...

UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure

... challenge, some subjects exhibited transient symptoms consistent with volume depletion and/or vasodilatation including dizziness, asymptomatic tachycardia and orthostatic hypotension. These events are indicative of a practical limit of pharmacologic activity in normal healthy subjects, and Nile intends ...
Tachycardia in Medical Products

Model 3510 Programmer

Description:... Jude Medical's universal programmer platform, the Model 3510 programming system, is used in combination with St. Jude Medical® bradycardia and tachycardia devices, including products for emerging indications. Features a large, color display on a touch-sensitive, active matrix LCD screen Programmer ...
Company:St. Jude Medical, Inc.

PSA Wand

Description:... System Analyzer (PSA Wand), model 3150, offers an integrated solution for implantation testing, programming and interrogation of bradycardia and tachycardia devices. Designed as an easy-to-use accessory to the St. Jude Medical model 3510 programmer Facilitates implantation testing by obtaining ...
Company:St. Jude Medical, Inc.

Chilli II Cooled Ablation Catheters

Description:... performance of the Boston Scientific Blazer(R) catheter platform. Cooled cardiac ablation is a recent advancement in the treatment of ventricular tachycardia (VT) using radio frequency (RF) energy. VT is a serious cardiac arrhythmia characterized by heart rates above 100 beats per minute. The Boston ...
Company:Boston Scientific Corporation

Maximo VR Model 7232

Description:... also experience atrial fibrillation. Painless antitachycardia pacing (ATP) therapy to terminate three-out-of-four episodes of fast ventricular tachycardia (VT)47 Enhanced PR Logic dual-chamber detection achieving 95.2% accuracy (positive predictive value - PPV) in delivered therapies48 The ...
Company:Medtronic Inc.

Tupos LA

Description:... against cardiac remodeling. Tupos LA uses biatrial stimulation to effectively suppress the typical symptomatic and medicine resistant atrial tachycardia of patients with interatrial blockages. The system is simple and quick to ....
Company:Biotronik GmbH & Co.

Contak Renewal® 2

Description:... or left ventricle only to synchronize ventricular contractions. The device provides ventricular tachyarrhythmia therapy to treat ventricular tachycardia (VT) and ventricular fibrillation (VF), rhythms that are associated with sudden cardiac death ....
Company:Guidant Corporation

ALTO2 DR, Dual Chamber ICD

Description:... A dual chamber sensing/pacing, rate responsive, 31 J ICD, with ELA's patented PARAD/PARAD+ ventricular tachycardia ....
Company:ELA Medical, Inc.

ALTO2 VR

Description:... A single chamber sensing/pacing, rate responsive, 31 J ICD, with a full range of ventricular tachycardia ....
Company:ELA Medical, Inc.

Vitality DS VR

Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation

Vitality DS

Features:... AV Search Hysteresis can reduce unnecessary right ventricular (RV) pacing Shock if Unstable may reduce painful shocks for fast ventricular tachycardia (VT) One-button Detection Enhancement for SVT discrimination Long-lasting FullView EGMs provide 3-channel Onset EGMs with no ...
Company:Guidant Corporation

More>>

Tachycardia in Medical Definition

Pathology

... - Long QT syndrome - Cardiac arrest - tachycardia ( Supraventricular tachycardia , AV nodal reentrant tachycardia , ...

Numbering aberrant rhythms

... abnormal beats. If these concurrent beats number three, they are called triplets and are considered as a brief run of non-sustained Ventricular tachycardia or NS-VT. PVC's are not the only aberrant beat that makes use of these adjectives; others are premature atrial contractions , parasystole , and ...
Tachycardia in Medical Dictionary

Arrhythmia

... Arrhythmia s can be divided into 2 main groups: tachycardia s and bradycardia s. tachycardia s cause a rapid heartbeat , with over 100 beats ... s may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ...

Arrhythmias

... Arrhythmias can be divided into 2 main groups: tachycardia s and bradycardia s. tachycardia s cause a rapid heartbeat , with over 100 beats ... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ...

Atria

... l fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... atria The ... (GS 840) See Preveon. Paroxysm al atria l tachycardia (PAT) and paroxysm al supra ...

Atrial fibrillation

... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... such as atrial fibrillation , supra ventricular tachycardia , or sinus ...

Atrial flutter

... ( Coronary Heart Disease ) ... Examples of tachycardia s may include a fast, irregular heart rhythm ... currently in sinus rhythm. Supra ventricular tachycardia Atrial flutter Rare types of ventricular tachycardia More recently, doctors have used catheter ...

Bradycardia

... the Middle - Normal Heart Rhythm - Ventricular tachycardia ... 4 - Bradycardia is when the heart ... greater than 100 beats per minutes is called a tachycardia . If your heart rate is too fast (known as a tachycardia ), too slow (known as a bradycardia ) or very ...

Cardioversion

... . Cardioversion . If you have an atria l tachycardia , including atrial fibrillation , your doctor ... such as atrial fibrillation , supra ventricular tachycardia , or sinus tachycardia . You may need medicine, electrical ...

Fibrillation

... fibrillation /flutter Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Palpitations Fainting ... - atrial ... as atrial fibrillation , supra ventricular tachycardia , or sinus ...

Heart block

... may be present, such as supra ventricular tachycardia (SVT) or complete heart block . Cardiac ... pacemaker s. Multi focal atria l tachycardia Paroxysm al supra ventricular tachycardia Wolff- Parkinson -White syndrome Sinus ...

Hunter syndrome

... ) Supinator ( High Arch es) Supra ventricular tachycardia ( Paroxysm al Supra ventricular tachycardia ) SVT ( Paroxysm al Supra ventricular tachycardia ) Swayback ( Lordosis ) ... ...

More>>

Tachycardia in Biological News

Targeted drug therapy prevents exercise-induced arrhythmias

... risk for sudden death, but ongoing arrhythmias can result in frequent stressful shocks. The Dutch patient, for example, experienced ventricular tachycardia and ICD shocks whenever he got out of bed, Knollmann said. Defibrillator therapy also can be problematic for pediatric patients (CPVT is usually ...

Studies point to novel target for treating arrhythmias

... The researchers examined the heart rhythms of mice expressing various troponin mutants that cause HCM and showed that the mice develop ventricular tachycardia (a particular arrhythmia). The risk for this arrhythmia was directly related to the degree of calcium sensitization caused by the troponin mutation: ...

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

... Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB ...

Fish oil -- helpful or harmful?

... such as men with stable angina. The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are not taking antiarrhythmic medications. Fish oils have promise as beneficial in cardiovascular disease but our work highlights our gaps ...

University of Pittsburgh cardiologists identify new cardiac arrest gene

... lead to less current flow and shorter heart beats in a part of the heart. This puts patients at risk for rapid heart rhythms such as ventricular tachycardia and fibrillation. Symptoms often present with no warning, and the seemingly healthy patient passes out and/or suffers a sudden cardiac arrest from an ...

Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure

... to understand the characteristics of ventricular tachycardia -- a condition characterized by abnormally fast ... death can result within minutes. "Ventricular tachycardia and fibrillation are the leading causes of sudden ... engineered tissues as would occur in ventricular tachycardia and attempted to halt it with pace-setting ....

Researchers link two more genes to sudden infant death syndrome

... gene. RyR2 was targeted because of its involvement in a distinct genetic heart rhythm disease known as catecholaminergic polymorphic ventricular tachycardia (CPVT). "For a parent whose infant died suddenly and mysteriously even five years ago, we were essentially unable to provide them with a cause and ...
Tachycardia in Biological Technology

Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results

... with paroxysmal supraventricular tachycardia (PSVT). PSVT is a condition characterized ... for the treatment of paroxysmal supraventricular tachycardia in Q1 2009. Duska's CDP-1050 is expected to ... for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, Duska's ...

Cordex Pharma Forms Heart Failure Medical Advisory Board

... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, and CDP-1050's expected ...

Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29

... a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia early in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 ... Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement ...

Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment

... is a proposed product for the termination of paroxysmal supraventricular tachycardia (PSVT). The bradycardic effect of ATP, in particular its blockade of ... patients presenting to the emergency room with paroxysmal supraventricular tachycardia (PSVT) should be sufficient to demonstrate clinical safety and efficacy, ...

Cordex Completes Production of ATPace(TM) Clinical Trial Material

... Research, Inc. The CTM will be used in the planned clinical trials for the acute treatment of patients presenting with paroxysmal supraventricular tachycardia (PSVT) in the emergency room. Several formulations of ATP have been used in Europe for over five decades as the drug of choice for the acute ...

Stereotaxis Showcases Advancements for Remote Magnetic Ablations

... partnered magnetic irrigated catheter, now available in Europe, is widely recognized as the gold standard for complex ablations such as ventricular tachycardia and complex left atrial arrhythmias. European clinicians have treated more than 600 patients with the magnetic irrigated catheter, with extremely ...

FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c

... includes new language noting that there was a significantly lower incidence of arrhythmias (ventricular tachycardia, bradycardia, supraventricular tachycardia and new atrial fibrillation) in patients treated with Ranexa versus placebo. This difference in arrhythmias did not lead to a reduction in mortality, ...

Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor

... with embedded algorithms that automatically detect, record and immediately transmit asymptomatic events such as atrial fibrillation, bradycardia, tachycardia and cardiac pause. A photo of the ER920W is available at http://www.biotelinc.com/images/BraemarER920W.jpg . Braemar, Inc., designs, develops, ...

CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection

... Less frequent side effects reported in patients administered Adenoscan include second and third degree AV block, fatal cardiac arrest, ventricular tachycardia and nonfatal myocardial infarction. For full prescribing information, please visit http://www.adenoscan.com . About CV Therapeutics CV ...

Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)

... Ranexa compared to placebo in the MERLIN TIMI-36 study. Patients receiving Ranexa had a 37 percent reduction in their relative risk of ventricular tachycardia lasting eight beats or more (p<0.001) and there were fewer episodes of sudden cardiac death observed in patients taking ranolazine (56) than in ...
Other Contents
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Not only ... create products free of petroleum, parabens and other cancer-causing ... that fund research, education and awareness programs that help ... staff and owners have raised an incredible, record-breaking contribution ... the Cure, sales of the Sweet Red Rose Whip ...
(Date:11/28/2014)... Hamilton, ON Canada (PRWEB) November 28, 2014 ... labels for the stuff kids lose® and an award-winning ... Julie Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby ... Entrepreneur Award. They were recognized with the PROFIT Award ... Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby) accepted ...
(Date:11/28/2014)... Lice Troopers Lice Removal Service is pleased to ... lice service for moms in Miami-Dade County. Lice Troopers is ... on Pone De-leon Blvd in Miami. The company currently ... Miami-Dade & Broward. Lice Troopers is the only Lice Clinic ... been treating families for several years. , Lice Troopers estimate ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic ... equipment to its students. That is why the ... play structure at its mental health services facility ... programs for children who are identified as needing ... have served the needs of children with severe ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
(Date:11/4/2014)... examining only marketing directed at children on the ... found that the majority of black, middle-income and ... tactics. , Authored by Arizona State University researcher ... the first to examine the use of child-directed ... food restaurants and its relationship to demographics. It ...
(Date:11/4/2014)... 4, 2014   Neurotechnology , a provider ... the latest version of its fingerprint matching algorithm ... MINEX evaluation organized by NIST. The MINEX ... the INCITS 378 fingerprint standard template format. MINEX ... tenders in the United States ...
(Date:11/3/2014)... ANGELES , Nov. 3, 2014  NeuroSigma ... -based life sciences company focused on commercialization ... system for the treatment of neurological and ... of Industrial Property has issued a Notice of ... patent application is co-owned by NeuroSigma and the ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
Other TagsOther Tags